Injective
INJ
Fundamental comparison between Injective and Zilliqa
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Injective
Coverage: 10/13 · 74%
Calculated:
Zilliqa
Coverage: 10/13 · 74%
Calculated:
Detailed Comparison
| Metric | Injective | Zilliqa |
|---|---|---|
| Price | $7.27 | $0.001786 |
| Market Cap | $726.73M | $34.85M |
| 24h Volume | 62.2M | 2.3M |
| Rank | #87 | #587 |
| Circulating Supply | 100M | 19.5B |
| ATH | $52.62 | $0.255376 |
Injective vs Zilliqa — Analysis
Comparison of Injective and Zilliqa: published market readings and a Value Score using up to 13 model components. Sourced project profiles add purpose, token role and risks where available.
Value Score Comparison
Injective: 76.5/100; Zilliqa: 79.2/100. No direct score comparison: calculation timestamp differ or are unrecorded.
Market Capitalization
Injective has 20.85 times the market capitalization of Zilliqa. This ratio measures market size; it does not establish volatility or future returns.
Price Performance
Reported price change over 24 hours: Injective 3.64%, Zilliqa -1.26%. Over 7 days: Injective -10.19%, Zilliqa -10.67%. Missing readings are shown as —.
Distance from All-Time High
Injective trades at 13.82% of its reported all-time high; Zilliqa at 0.7%. This distance describes price history and is not a standalone buy signal.
Conclusion
The readings show differences in market value and model assessment. Project purpose, token rights, risks, source dates and data coverage also matter. A higher score does not predict higher returns or lower risk.